GTR Home > Tests > Search results - Charcot-Marie-Tooth disease dominant intermediate 3

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 2255 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1843075[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 42 tests for 1 condition in 11 labs

CDI-CMTD

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCharcot-Marie-Tooth Disease

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (45)
Total targets (30)

CMPZ

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (7)

CCharcot Marie Tooth Disease Extended NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (115)
Total targets (49)

CCharcot-Marie-Tooth disease, autosomal dominant

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (18)

CCharcot-Marie-Tooth disease, dominant intermediate

Lab: Invitae San Francisco, California, United States

CCharcot-Marie-Tooth disease, full panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (42)
Total targets (28)

CMPZ, MFN2. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain

CCMT Advanced Evaluation - Demyelinating

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (22)
Total targets (15)

CCMT Advanced Evaluation - Axonal

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (13)

CCMT Advanced Evaluation - Comprehensive

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (31)
Total targets (23)

CCMT Advanced Evaluation - Dominant, Demyelinating

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (6)

CCMT Advanced Evaluation - Dominant

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (18)
Total targets (13)

CXLID NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (188)
Total targets (107)

CNuclear-Mito NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (601)
Total targets (504)

CSpastic Paraplegia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (45)
Total targets (25)

CSudden Death Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Total conditions (185)
Total targets (68)

CHearing Loss NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (202)
Total targets (103)

CParkinson-Alzheimer-Dementia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (82)
Total targets (37)

Showing 1 to 20 of 42 tests for 1 condition in 11 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.